Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roche Holding AG (DE:RHO5)
XETRA:RHO5
Roche Holding AG (RHO5) Stock Price & Analysis
62 Followers
RHO5 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€244.35 - €247.10
Previous Close€245.2
Volume2.84K
Average Volume (3M)2.84K
Market Cap
€233.03B
Enterprise Value€255.45B
Total Cash (Recent Filing)CHF7.51B
Total Debt (Recent Filing)CHF25.39B
Price to Earnings (P/E)16.6
BetaN/A
Next Earnings
Jul 25, 2024EPS Estimate
€9.67Last Dividend Ex-Date
Mar 14, 2024Dividend Yield3.48%
Share Statistics
EPS (TTM)14.78
Shares Outstanding702,562,700
10 Day Avg. Volume0
30 Day Avg. Volume2,836
Standard Deviation0.05
R-Squared0.04
Alpha0.00155
Financial Highlights & Ratios
Price to Book (P/B)93.14
Price to Sales (P/S)2.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€269.89Price Target Upside10.07% Upside
Rating ConsensusHold
Number of Analyst Covering12
Roche Holding AG News
Bulls Say, Bears Say
Bulls Say
Clinical Trial ResultsPositive top-line phase 1 data for oral once-daily GLP-1R agonist CT-996 in people with obesity without diabetes, shows 6.1% placebo-adjusted weight loss.
Financial PerformanceThe shares are expected to continue to outperform due to substantial earnings upgrade potential driven mostly by established franchises.
Sales GrowthExcluding the CV19 headwind, group, pharma, and diagnostics sales grew at highly respectable rates of 7%, 7% and 8% respectively.
Bears Say
Financial PerformanceThe largest downside risks include Vabysmo and Phesgo delivering only the consensus forecasts and the group margin not expanding between 2023 and 2029.
ForecastsUpgrades to the consensus forecasts are unlikely right now.
TransparencyImportant baseline characteristics and PK/PD parameters are not disclosed, making cross-trial comparisons difficult.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
19.79% Mutual Funds
9.35% Other Institutional Investors
70.85% Public Companies and
Individual Investors
RHO5 FAQ
What was Roche Holding AG’s price range in the past 12 months?
Roche Holding AG lowest stock price was €244.35 and its highest was €247.10 in the past 12 months.
What is Roche Holding AG’s market cap?
Currently, no data Available
When is Roche Holding AG’s upcoming earnings report date?
Roche Holding AG’s upcoming earnings report date is Jul 25, 2024 which is in 3 days.
How were Roche Holding AG’s earnings last quarter?
Roche Holding AG released its earnings results on Feb 01, 2024. The company reported €8.748 earnings per share for the quarter, beating the consensus estimate of €8.645 by €0.103.
Is Roche Holding AG overvalued?
According to Wall Street analysts Roche Holding AG’s price is currently Undervalued.
Does Roche Holding AG pay dividends?
Roche Holding AG pays a Annually dividend of €9.92 which represents an annual dividend yield of 3.48%. See more information on Roche Holding AG dividends here
What is Roche Holding AG’s EPS estimate?
Roche Holding AG’s EPS estimate is €9.67.
How many shares outstanding does Roche Holding AG have?
Roche Holding AG has 702,562,700 shares outstanding.
What happened to Roche Holding AG’s price movement after its last earnings report?
Roche Holding AG reported an EPS of €8.748 in its last earnings report, beating expectations of €8.645. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Roche Holding AG?
Currently, no hedge funds are holding shares in DE:RHO5
---
Roche Holding AG Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€269.89 (10.07% Upside)
€269.89 (10.07% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-2.03%
12-Months-Change
Fundamentals
Return on Equity
39.18%
Trailing 12-Months
Asset Growth
12.82%
Trailing 12-Months
Company Description
Roche Holding AG
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
---
RHO5 Company Deck
---
RHO5 Earnings Call
Q4 2024
0:00 / 0:00
---
RHO5 Stock 12 Month Forecast
Average Price Target
€269.89
▲(10.07% Upside)
Technical Analysis
Best Analysts Covering RHO5
1 Year
1 Year Success Rate
25/39 ratings generated profit
1 Year Average Return
+5.72%
reiterated a sell rating 5 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 64.10% of your transactions generating a profit, with an average return of +5.72% per trade.
---